PTH TREATMENT REGIMEN COMPRISING TWO PTH COMPOUNDS
Applicants:
- ASCENDIS PHARMA BONE DISEASES AS [NORA names: Ascendis Pharma; Private Research]
Abstract
The present invention relates to a PTH compound for use in the treatment of chronic hypoparathyroidism, wherein the treatment comprises the step of administering to a patient having chronic hypoparathyroidism a once weekly dose of a PTH compound and wherein prior to initiation of the treatment the patient is clinically determined as being no longer dependent on active vitamin D and calcium supplement to maintain serum within normal range; and related aspects.
Patent Family Records (1)
PTH TREATMENT REGIMEN COMPRISING TWO PTH COMPOUNDS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, ANDERSON THOMAS WILLIAM
2024, WO-2024094673-A1